Moderna's combo flu and Covid jab boosts protection
Summary: A clinical trial by Moderna shows a combined flu and Covid vaccine elicits higher immune responses than separate shots. Results from a phase 3 trial of 8,000 participants indicate increased protection against both diseases. Moderna aims to make the vaccine widely available next year. CEO Stéphane Bancel highlights the potential of combination vaccines in reducing respiratory virus burdens. Boots in England offers Pfizer-BioNTech jabs for £98.95 to customers aged 12 and over.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
We analyze up to 10,000 news articles daily and find the most significant world news.
Read more about how we calculate significance, or see today's top rated news on the main page:
See today's news rankings